Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-speranza COVID-19 Project study protocol

Category Primary study
ConferenceBasic and Clinical Pharmacology and Toxicology
Year 2022
This article has no abstract
Epistemonikos ID: 8cba8c067e5102918e268219d336eadca125dc20
First added on: Apr 30, 2026